MoneyWorks4Me

Vivo Bio Tech informs about quarterly statement of investor complaint

14 Jan 2016 Evaluate

Vivo Bio Tech has informed about quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech Share Price

19.40 -0.70 (-3.48%)
17-Aug-2026 14:24 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1897.60
Dr. Reddys Labs. 1192.90
Cipla 1430.50
Lupin 2257.15
Zydus Lifesciences 1138.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: